Modification or dose or treatment duration has no impact on outcome of AML patients: preliminary results of the UK NCRI AML 14 trail

AK Burnett, Donald Milligan, AG Prentice, A Goldstone, A McMullin, Robert Hills, Keith Wheatley

Research output: Contribution to journalAbstract

Original languageEnglish
Pages (from-to)162a
Issue number11
Publication statusPublished - 1 Jan 2005

Cite this